EquityZen Growth Technology Fund LLC - Series 1184
Raised
$177K
Investors
11
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1184 is a Delaware pooled investment fund filed on March 23, 2022, by EquityZen Advisors LLC and Assure Fund Management II LLC. The fund raised $177K from 11 investors with a $10K minimum investment, relying on Rule 506(b) and Section 3(c)(1) exemptions. It is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO fund follows the standard EquityZen series structure: a small-scale 506(b) vehicle with 3(c)(1) exemption, a low $10K minimum enabling retail-adjacent access, and modest capital aggregation. The raise size and investor count are consistent with single-name secondary equity positions in private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.